6881 results
Cited 8 times since 2009 (0.5 per year)
source: EuropePMC
IEEE transactions on ultrasonics, ferroelectrics, and frequency control,
Volume 56, Issue 6, 1 1 2009, Pages 1199-1206
Contrast agent response to chirp reversal: simulations, optical observations, and acoustical verification.
Novell A, van der Meer S, Versluis M, de Jong N, Bouakaz A
Active response of a microbubble is characterized by its resonance behavior where the microbubble might oscillate after the excitation waveform has been turned off. We investigate in this paper an excitation approach based on this resonance phenomenon using chirps. The technique, called chirp reversal, consists in transmitting a first excitation signal, the up-sweep chirp (UPF) of increasing frequency with time, and a second excitation signal, the down-sweep (DNF) that is a replica of the first...
Abstract
Cited 28 times since 2009 (1.8 per year)
source: EuropePMC
Diabetes care,
Volume 32, Issue 8, 1 1 2009, Pages 1507-1512
Differences in atherosclerotic plaque burden and morphology between type 1 and 2 diabetes as assessed by multislice computed tomography.
Djaberi R, Schuijf JD, Boersma E, Kroft LJ, Pereira AM, Romijn JA, Scholte AJ, Jukema JW, Bax JJ
OBJECTIVE It is unclear whether the coronary atherosclerotic plaque burden is similar in patients with type 1 and type 2 diabetes. By using multislice computed tomography (MSCT), the presence, degree, and morphology of coronary artery disease (CAD) in patients with type 1 and type 2 diabetes were compared. RESEARCH DESIGN AND METHODS Prospectively, coronary artery calcium (CAC) scoring and MSCT coronary angiography were performed in 135 asymptomatic patients (65 patients with type 1 diabetes and...
Abstract
Cited 8 times since 2009 (0.5 per year)
source: EuropePMC
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation,
Volume 17, Issue 6, 1 1 2009, Pages 262-264
A genome wide association analysis in the GENDER study.
Sampietro ML, Pons D, de Knijff P, Slagboom PE, Zwinderman A, Jukema JW
Percutaneous coronary intervention (PCI) has become an effective therapy to treat coronary artery diseases. However, one of the major drawbacks of PCI is the occurrence of restenosis in 8 to 40% of all treated patients. The GENetic Determinants of Restenosis (GENDER) project was designed to study the association between genetic polymorphisims and clinical restenosis. The discovery of genetic variants associated to the occurrence of restenosis after PCI may provide a more tailored therapy and may...
Abstract
Cited 329 times since 2009 (20.9 per year)
source: EuropePMC
Heart rhythm,
Volume 6, Issue 6, 1 1 2009, Pages 886-933
EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA).
Aliot EM, Stevenson WG, Almendral-Garrote JM, Bogun F, Calkins CH, Delacretaz E, Della Bella P, Hindricks G, Jaïs P, Josephson ME, Kautzner J, Kay GN, Kuck KH, Lerman BB, Marchlinski F, Reddy V, Schalij MJ, Schilling R, Soejima K, Wilber D, European Heart Rhythm Association (EHRA), Registered Branch of the European Society of Cardiology (ESC), Heart Rhythm Society (HRS), American College of Cardiology (ACC), American Heart Association (AHA)
Abstract
Cited 1 times since 2009 (0.1 per year)
source: EuropePMC
European heart journal,
Volume 30, Issue 13, 31 5 2009, Pages 1554-1555
Towards assessment of left ventricular mechanics in true three dimensions.
Delgado V, Bax JJ, van der Wall EE
Abstract
Cited 58 times since 2009 (3.7 per year)
source: EuropePMC
Basic research in cardiology,
Volume 104, Issue 5, 26 4 2009, Pages 485-498
Coronary microvascular resistance: methods for its quantification in humans.
Knaapen P, Camici PG, Marques KM, Nijveldt R, Bax JJ, Westerhof N, Götte MJ, Jerosch-Herold M, Schelbert HR, Lammertsma AA, van Rossum AC
Coronary microvascular dysfunction is a topic that has recently gained considerable interest in the medical community owing to the growing awareness that microvascular dysfunction occurs in a number of myocardial disease states and has important prognostic implications. With this growing awareness, comes the desire to accurately assess the functional capacity of the coronary microcirculation for diagnostic purposes as well as to monitor the effects of therapeutic interventions that are targeted...
Abstract
The international journal of cardiovascular imaging,
Volume 25, Issue 6, 26 4 2009, Pages 643-645
Cardiac magnetic resonance imaging in primary PCI: additional value?
van der Wall EE, Bax JJ, Jukema JW, Schalij MJ
Abstract
Cited 1533 times since 2009 (97.1 per year)
source: EuropePMC
Science (New York, N.Y.),
Volume 325, Issue 5937, 22 4 2009, Pages 197-201
Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans.
Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, Okomo-Adhiambo M, Gubareva L, Barnes J, Smith CB, Emery SL, Hillman MJ, Rivailler P, Smagala J, de Graaf M, Burke DF, Fouchier RA, Pappas C, Alpuche-Aranda CM, López-Gatell H, Olivera H, López I, Myers CA, Faix D, Blair PJ, Yu C, Keene KM, Dotson PD, Boxrud D, Sambol AR, Abid SH, St George K, Bannerman T, Moore AL, Stringer DJ, Blevins P, Demmler-Harrison GJ, Ginsberg M, Kriner P, Waterman S, Smole S, Guevara HF, Belongia EA, Clark PA, Beatrice ST, Donis R, Katz J, Finelli L, Bridges CB, Shaw M, Jernigan DB, Uyeki TM, Smith DJ, Klimov AI, Cox NJ
Since its identification in April 2009, an A(H1N1) virus containing a unique combination of gene segments from both North American and Eurasian swine lineages has continued to circulate in humans. The lack of similarity between the 2009 A(H1N1) virus and its nearest relatives indicates that its gene segments have been circulating undetected for an extended period. Its low genetic diversity suggests that the introduction into humans was a single event or multiple events of similar viruses. Molecu...
Abstract
Cited 21 times since 2009 (1.3 per year)
source: EuropePMC
European heart journal,
Volume 30, Issue 13, 22 4 2009, Pages 1559-1564
The current status of interventions aiming at reducing sudden cardiac death in dialysis patients.
de Bie MK, van Dam B, Gaasbeek A, van Buren M, van Erven L, Bax JJ, Schalij MJ, Rabelink TJ, Jukema JW
Mortality in dialysis patients is extremely high, with an annual death rate of approximately 23%. Sudden cardiac death (SCD) is the single largest cause of death in dialysis patients accounting for approximately 60% of all cardiac deaths and 25% of all-cause mortality. Interventions aiming at reducing cardiovascular mortality, especially SCD, in dialysis patients are therefore extremely important and clinically highly relevant. The purpose of this review is to give an outline of the epidemiology...
Abstract
Cited 195 times since 2009 (12.3 per year)
source: EuropePMC
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology,
Volume 11, Issue 6, 14 2 2009, Pages 771-817
EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA).
Aliot EM, Stevenson WG, Almendral-Garrote JM, Bogun F, Calkins CH, Delacretaz E, Bella PD, Hindricks G, Jaïs P, Josephson ME, Kautzner J, Kay GN, Kuck KH, Lerman BB, Marchlinski F, Reddy V, Schalij MJ, Schilling R, Soejima K, Wilber D, European Heart Rhythm Association, European Society of Cardiology, Heart Rhythm Society
Abstract
Cited 24 times since 2009 (1.5 per year)
source: EuropePMC
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology,
Volume 16, Issue 3, 13 2 2009, Pages 376-383
Type 2 diabetes is associated with more advanced coronary atherosclerosis on multislice computed tomography and virtual histology intravascular ultrasound.
Pundziute G, Schuijf JD, Jukema JW, van Werkhoven JM, Nucifora G, Decramer I, Sarno G, Vanhoenacker PK, Reiber JH, Wijns W, Bax JJ
Background: Data on coronary plaque observations on multi-slice computed tomography (MSCT) in patients with type 2 diabetes are scarce. Methods and results: In total, 60 patients (19 with diabetes) underwent 64-slice MSCT, followed by conventional coronary angiography with intravascular ultrasound (IVUS). Non-invasively, the extent of coronary atherosclerosis and 3 plaque types (non-calcified, calcified, mixed) were visually evaluated on MSCT. Invasively, plaque burden was assessed on gray-scale...
Abstract
Cited 39 times since 2009 (2.5 per year)
source: EuropePMC
European journal of nuclear medicine and molecular imaging,
Volume 36, Issue 10, 9 2 2009, Pages 1622-1628
Evaluation and comparison of 11C-choline uptake and calcification in aortic and common carotid arterial walls with combined PET/CT.
Kato K, Schober O, Ikeda M, Schäfers M, Ishigaki T, Kies P, Naganawa S, Stegger L
Purpose: Inflamed atherosclerotic plaques may rupture and cause acute myocardial infarction, stroke and other thrombotic events. Early detection of these unstable plaques could, in many cases, prevent such potentially fatal events. 11C-choline or 18F-labelled choline derivatives for visualizing the synthesis of phospholipids, are promising markers of plaque inflammation with potential advantages over 18F-FDG. Their potential for plaque characterization in humans is, however, unclear. In this stu...
Abstract
Cited 9 times since 2009 (0.6 per year)
source: EuropePMC
International journal of chronic obstructive pulmonary disease,
Volume 4, 7 1 2009, Pages 177-183
Beta-blockers and health-related quality of life in patients with peripheral arterial disease and COPD.
van Gestel YR, Hoeks SE, Sin DD, Stam H, Mertens FW, Bax JJ, van Domburg RT, Poldermans D
Background: Beta-blockers are frequently withheld in patients with cardiovascular disease who also have chronic obstructive pulmonary disease (COPD) because of concerns that they might provoke bronchospasm and cause deterioration in health status. Although beta1-selective beta-blockers are associated with reduced mortality in COPD patients, their effects on health status are unknown. The aim of this study was to investigate the relationship between beta-blockers and health-related quality of lif...
Abstract
Cited 21 times since 2009 (1.3 per year)
source: EuropePMC
Acta anaesthesiologica Scandinavica,
Volume 53, Issue 7, 6 1 2009, Pages 941-948
Anti-ischemic effects of inotropic agents in experimental right ventricular infarction.
Hein M, Roehl AB, Baumert JH, Scherer K, Steendijk P, Rossaint R
Background: Right ventricular (RV) function is an important determinant of survival after myocardial infarction. The efficacy of reperfusion therapy might be increased by the cardioprotective action of inotropic agents, which are used for symptomatic therapy in situations with compromised hemodynamics. Therefore, we used a porcine model of RV ischemia and reperfusion (IR) injury to study the influence of milrinone, levosimendan and dobutamine on the extent and degree of myocardial injury. Method...
Abstract
Cited 40 times since 2009 (2.5 per year)
source: EuropePMC
Current medical research and opinion,
Volume 25, Issue 5, 1 1 2009, Pages 1171-1178
Physicians' attitudes and adherence to use of risk scores for primary prevention of cardiovascular disease: cross-sectional survey in three world regions.
Sposito AC, Ramires JA, Jukema JW, Molina JC, da Silva PM, Ghadanfar MM, Wilson PW
Objective: To evaluate physicians' attitudes and adherence to the use of risk scores in the primary prevention of cardiovascular disease (CVD). Design and methods: A cross-sectional survey of 2056 physicians involved in the primary prevention of CVD. Participants included cardiologists (47%), general practitioners (42%), and endocrinologists (11%) from several geographical regions: Brazil (n = 968), USA (n = 381), Greece (n = 275), Chile (n = 157), Venezuela (n = 128), Portugal (n = 42), Th...
Abstract
Cited 2 times since 2009 (0.1 per year)
source: EuropePMC
Cardiology clinics,
Volume 27, Issue 2, 1 1 2009, Pages 265-76, Table of Contents
Nuclear imaging in heart failure.
Bax JJ, Boogers MM, Schuijf JD
Heart failure is becoming the main clinical challenge in cardiology in the twenty-first century and is associated with high morbidity and mortality. Currently, several therapeutic options are available for heart failure patients, including medical therapy, revascularization, advanced cardiac surgery, device therapy, and cardiac transplantation. Future therapies are directed at cell and gene therapy. In this article the role of nuclear imaging in the management of heart failure patients is discus...
Abstract
Cited 2 times since 2009 (0.1 per year)
source: EuropePMC
Chronobiology international,
Volume 26, Issue 4, 1 1 2009, Pages 637-652
Myocardial infarction occurs with a similar 24 h pattern in the 4G/5G versions of plasminogen activator inhibitor-1.
Bergheanu SC, Pons D, Jukema JW, van der Hoeven BL, Liem SS, Vandenbroucke JP, Rosendaal FR, le Cessie S, Schalij MJ, van der Bom JG
PAI-1 expression is regulated by a 4G/5G promoter polymorphism. The 4G allele is associated with greater circadian variation of PAI-1 levels. We hypothesized that the 24 h variation of cardiac risk is more pronounced among persons with the 4G4G genotype than among ones with 4G5G and 5G5G genotypes. We assessed the time of onset of symptoms in 623 consecutive patients with acute myocardial infarction (AMI) enrolled in the MISSION! Study between February 1, 2004, and October 29, 2006. All of the p...
Abstract
Cited 177 times since 2009 (11.2 per year)
source: EuropePMC
JAMA,
Volume 301, Issue 19, 1 1 2009, Pages 1997-2004
Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial.
van Ramshorst J, Bax JJ, Beeres SL, Dibbets-Schneider P, Roes SD, Stokkel MP, de Roos A, Fibbe WE, Zwaginga JJ, Boersma E, Schalij MJ, Atsma DE
Context: Previous studies have suggested that bone marrow cell injection may improve myocardial perfusion and left ventricular (LV) function in patients with chronic myocardial ischemia. Objective: To investigate the effect of intramyocardial bone marrow cell injection on myocardial perfusion and LV function in patients with chronic myocardial ischemia. Design, setting, and patients: Randomized, double-blind, placebo-controlled trial at a Netherlands university hospital, May 1, 2005-March 3, 200...
Abstract
Cited 107 times since 2009 (6.8 per year)
source: EuropePMC
Journal of the American College of Cardiology,
Volume 53, Issue 21, 1 1 2009, Pages 1933-1943
Echocardiography and noninvasive imaging in cardiac resynchronization therapy: results of the PROSPECT (Predictors of Response to Cardiac Resynchronization Therapy) study in perspective.
Bax JJ, Gorcsan J
Abstract
Cited 31 times since 2009 (2 per year)
source: EuropePMC
Coronary artery disease,
Volume 20, Issue 3, 1 1 2009, Pages 219-224
Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
Goei D, Hoeks SE, Boersma E, Winkel TA, Dunkelgrun M, Flu WJ, Schouten O, Bax JJ, Poldermans D
Objectives: High-sensitivity C-reactive protein (hs-CRP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) are associated with the presence of coronary artery disease. The aim of this study was to assess the prognostic value of hs-CRP and NT-proBNP for postoperative cardiac events in noncardiac vascular surgery patients. Methods: In 592 patients, cardiac history, hs-CRP, and NT-proBNP levels were assessed preoperatively. Levels of hs-CRP of at least 6.5 mg/l and NT-proBNP of at least 350...
Abstract
